Luke F. Chen
About
Luke F. Chen is a scholar working on Epidemiology, Infectious Diseases and Surgery.
According to data from OpenAlex, Luke F. Chen has authored 82 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 34 papers in Infectious Diseases and 19 papers in Surgery. Recurrent topics in Luke F. Chen's work include Surgical site infection prevention (16 papers), Antimicrobial Resistance in Staphylococcus (15 papers) and Antibiotic Resistance in Bacteria (14 papers). Luke F. Chen is often cited by papers focused on Surgical site infection prevention (16 papers), Antimicrobial Resistance in Staphylococcus (15 papers) and Antibiotic Resistance in Bacteria (14 papers). Luke F. Chen collaborates with scholars based in United States, Australia and Ukraine. Luke F. Chen's co-authors include Daniel J. Sexton, Deverick J. Anderson, Rebekah W. Moehring, Sarah S. Lewis, Becky A. Miller, Keith S. Kaye, David J. Weber, William A. Rutala, Lauren P. Knelson and Vance G. Fowler and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.
In The Last Decade
Luke F. Chen
77 papers receiving 3.1k citations
Peers
Luke F. Chen
Meghan Maloney United States
David A. Pegues United States
M. Lindsay Grayson Australia
Carol Chenoweth United States
Ralf‐Peter Vonberg Germany
Zeina A. Kanafani Lebanon
Stefan P. Kuster Switzerland
Connie Price United States
Kerri A. Thom United States
Cassandra D. Salgado United States
Citations per year, relative to Luke F. Chen Luke F. Chen (= 1×)
peers
Meghan Maloney
Countries citing papers authored by Luke F. Chen
Since
Specialization
Citations
This map shows the geographic impact of Luke F. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke F. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke F. Chen more than expected).
Fields of papers citing papers by Luke F. Chen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Luke F. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke F. Chen. The network helps show where Luke F. Chen may publish in the future.
Co-authorship network of co-authors of Luke F. Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Luke F. Chen. A scholar is included among the top collaborators of Luke F. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke F. Chen. Luke F. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bradley, John S., Camilla Tøndel, Emmanuel Roilides, et al.. (2023). Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Children with Confirmed or Suspected Gram‐Negative Bacterial Infections: A Phase 1b, Open‐Label, Single‐Dose Clinical Trial. The Journal of Clinical Pharmacology. 63(12). 1387–1397.
2.
Roberts, Jason A., David P. Nicolau, Ignacio Martín‐Loeches, et al.. (2023). Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearance. JAC-Antimicrobial Resistance. 5(2). dlad011–dlad011.
3.
Martín‐Loeches, Ignacio, Andrew F. Shorr, Marin H. Kollef, et al.. (2023). Participant- and Disease-Related Factors as Independent Predictors of Treatment Outcomes in the RESTORE-IMI 2 Clinical Trial: A Multivariable Regression Analysis. Open Forum Infectious Diseases. 10(6). ofad225–ofad225.
4.
Seidelman, Jessica, Richard J. Wallace, Elena Iakhiaeva, et al.. (2018). Mycobacterium avium pseudo-outbreak associated with an outpatient bronchoscopy clinic: Lessons for reprocessing. Infection Control and Hospital Epidemiology. 40(1). 106–108.
5.
Knelson, Lauren P., Luke F. Chen, Rebekah W. Moehring, et al.. (2017). Self-monitoring by Environmental Services May Not Accurately Measure Thoroughness of Hospital Room Cleaning. Infection Control and Hospital Epidemiology. 38(11). 1371–1373.
6.
Weber, David J., William A. Rutala, Deverick J. Anderson, et al.. (2016). Effectiveness of ultraviolet devices and hydrogen peroxide systems for terminal room decontamination: Focus on clinical trials. American Journal of Infection Control. 44(5). e77–e84.
7.
Knelson, Lauren P., Sarah S. Lewis, Rebekah W. Moehring, et al.. (2015). Evaluation of Community-Acquired Clostridium difficile Infection in North Carolina Using Geographic Information Systems and Spatial Statistics. Open Forum Infectious Diseases. 2(suppl_1).
8.
Baker, Arthur W., Michael J. Durkin, Kristen V. Dicks, et al.. (2014). Methicillin-Resistant Staphylococcus aureus Bloodstream Infection Surveillance: National Healthcare Safety Network’s Laboratory-Identified Event Reporting versus Traditional Laboratory-Confirmed Bloodstream Infection Surveillance. Infection Control and Hospital Epidemiology. 35(10). 1286–1289.
9.
Chen, Luke F., et al.. (2013). Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis. Expert Opinion on Pharmacotherapy. 14(11). 1529–1536.
10.
Lee, Mi Suk, et al.. (2013). The Epidemiology of Ventilator-Associated Pneumonia in a Network of Community Hospitals: A Prospective Multicenter Study. Infection Control and Hospital Epidemiology. 34(7). 657–662.
11.
Lewis, Sarah S., Lauren P. Knelson, Rebekah W. Moehring, et al.. (2013). Comparison of Non–Intensive Care Unit (ICU) versus ICU Rates of Catheter-Associated Urinary Tract Infection in Community Hospitals. Infection Control and Hospital Epidemiology. 34(7). 744–747.
12.
Chen, Luke F.. (2012). The changing epidemiology of methicillin-resistant Staphylococcus aureus: 50 years of a superbug. American Journal of Infection Control. 41(5). 448–451.
13.
Chen, Luke F., et al.. (2012). Observing and Improving Hand Hygiene Compliance Implementation and Refinement of an Electronic-Assisted Direct-Observer Hand Hygiene Audit Program. Infection Control and Hospital Epidemiology. 34(2). 207–210.
14.
Chen, Luke F., Matthew E. Falagas, & Anton Y. Peleg. (2011). Facing the rising tide of multidrug resistant Gram-negative pathogens. 16(1). 1–5.
15.
Chen, Luke F., Natalie Dailey Garnes, Agam K. Rao, et al.. (2011). Cluster of Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Virus Infections on a Hospital Ward among Immunocompromised Patients—North Carolina, 2009. The Journal of Infectious Diseases. 203(6). 838–846.
16.
Drew, Richard H., et al.. (2011). Ceftaroline fosamil for treatment of communityacquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy. Expert Review of Anti-infective Therapy. 9(8). 567–572.
17.
Chen, Luke F., Cody A. Chastain, & Deverick J. Anderson. (2011). Community-Acquired Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections: Management and Prevention. Current Infectious Disease Reports. 13(5). 442–450.
18.
Chen, Luke F., Daniel J. Sexton, Keith S. Kaye, & Deverick J. Anderson. (2009). Patient-days: A better measure of incidence of occupational bloodborne exposures. American Journal of Infection Control. 37(7). 534–540.
19.
Anderson, Deverick J., Keith S. Kaye, Luke F. Chen, et al.. (2009). Clinical and Financial Outcomes Due to Methicillin Resistant Staphylococcus aureus Surgical Site Infection: A Multi-Center Matched Outcomes Study. PLoS ONE. 4(12). e8305–e8305.
20.
Chen, Luke F. & Daniel J. Sexton. (2008). What's New in Rocky Mountain Spotted Fever?. Infectious Disease Clinics of North America. 22(3). 415–432.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Meghan Maloney Breakdown of academic impact, for papers by David A. Pegues Breakdown of academic impact, for papers by M. Lindsay Grayson Breakdown of academic impact, for papers by Carol Chenoweth Breakdown of academic impact, for papers by Ralf‐Peter Vonberg Breakdown of academic impact, for papers by Zeina A. Kanafani Breakdown of academic impact, for papers by Stefan P. Kuster Breakdown of academic impact, for papers by Connie Price Breakdown of academic impact, for papers by Kerri A. Thom Breakdown of academic impact, for papers by Cassandra D. Salgado